Bethesda, Md. – PDA is excited to announce the keynote speakers for the upcoming PDA/FDA Joint Regulatory Conference September 16-18 in Washington, D.C. These and other expert speakers will share their insight on how to improve the continued supply of high-quality drugs, biologics, and novel combination products to patients.
Marschall S. Runge, MD, PhD, Executive Vice President for Medical Affairs, University of Michigan will lead the “Academic and Clinical Perspective on Manufacturing Innovation and Achieving the 20/20 Vision” following the opening remarks about the keys to ensuring quality and promoting public health.
Then, Patrizia Cavazzoni, MD, Deputy Director for Operations, CDER, U.S. FDA, will share the “Regulatory Perspective.”
This year’s conference, themed “Manufacturing Innovation, Quality, and Compliance: Achieving 20/20 Vision,” will have 27presentations from the U.S. FDA and the other health authorities around the world. There will also be several panel discussions providing attendees an opportunity to ask the regulators questions, including the FDA Centers Updates session on Wednesday, September 18. On Tuesday, September 17, there is the “Lunch with Regulators” session, giving attendees a chance to interact with FDA investigators, reviewers, and compliance officers.
Go here to see the full conference agenda. https://www.pda.org/global-event-calendar/event-detail/2019-pda-fda-joint-regulatory-conference#agenda
Press passes are available here to bona fide members of the press. https://www.pda.org/about-pda/press-pass-request-form